📰 Expanded Access News
Page 9 - Expanded Access News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Expanded Access. Real-time updates on events, politics, business and more.
January 12, 2023
BOSTON, Jan. 12, 2023 /PRNewswire/ -- Data Bridge Market Research has recently published a Report, titled, "E-Clinical Solutions Market" The report offers an extensive analysis of key growth
January 3, 2023
The second Expanded Access patient (EA2) demonstrated additional clinical improvement in the Expanded Disability Status Scale (EDSS), a FDA recognized standard clinical outcome assessment score NEW
January 3, 2023
Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that the second patient (“EA2”) with non-active secondary progressive multiple sclerosis (SPMS) receiving intranasal ...
December 20, 2022
Congress recently introduced a bill that could expand access to therapeutic psychedelics that are designated as Breakthrough Therapies. These products are potentially useful in treating...
December 16, 2022
Congress recently introduced a bill that could expand access to therapeutic psychedelics that are designated as Breakthrough Therapies. These products are useful in treating addiction, depression, post-traumatic stress disorder PTSD, and other neurologic diseases.
December 16, 2022
Congress recently introduced a bill that could expand access to therapeutic psychedelics that are designated as Breakthrough Therapies. These products are potentially useful in treating...
November 29, 2022
The factors that are expected to act as drivers for the growth of the global exosome therapeutics market are the increased incidence of chronic...
November 29, 2022
A Qualitative Research Study accomplished by Data Bridge Market researchs database titled "Exosome Therapeutics Market" with 100+ market data Tables, Pie
November 23, 2022
Brainstorm Cell Therapeutics is seeking FDA approval of its mesenchymal stem cell therapy called NurOwn for the treatment of ALS. In response to the FDAs Refusal to File letter, and as people who... | November 23, 2022
November 22, 2022
/PRNewswire/ -- Brainstorm Cell Therapeutics is seeking FDA approval of its mesenchymal stem cell therapy called NurOwn for the treatment of ALS. In response...